mTORC1型
PI3K/AKT/mTOR通路
癌症研究
抗代谢物
淋巴瘤
生物
癌细胞
综合应力响应
细胞培养
抗药性
癌症
化学
细胞生长
基因沉默
下调和上调
生物化学
前药
药理学
二肽
流出
B细胞淋巴瘤
细胞毒性
雷帕霉素的作用靶点
生长抑制
作者
Haojun Yang,Vincenzo Andrea Zingaro,Kevin Boardman,Ashish Noronha,Ekin Güney,Lingru Xue,Saishma Hoigebazar,Isabelle Liu,Sohit Miglani,Siyu Chen,Hieu Vu,Kwun Wah Wen,Hao Gia Nguyen,Hani Goodarzi,Ralph J. DeBerardinis,Davide Ruggero
摘要
Antimetabolites, chemotherapy targeting nucleotide biosynthesis, are among the oldest and most widely used cancer treatments, yet resistance remains a daunting barrier, especially in the fight against B cell lymphomas. However, the underlying mechanisms of this resistance have long remained elusive. Using an innovative, integrated omics approach, we unexpectedly identified that the accumulation of dipeptides and upregulation of the dipeptide transporter SLC15A3 underlie resistance to nucleotide deficiency in a Myc-driven large B cell lymphoma mouse model. A similar mechanism occurred after long treatment of human B cell lymphoma cells with the chemotherapeutic purine synthesis inhibitor 6-mercaptopurine (6MP). Mechanistically, we demonstrated that dipeptides containing essential amino acids activated the growth and survival mTOR complex 1 (mTORC1) signaling pathway. Notably, SLC15A3 specifically interacted with mTOR on the lysosome, boosting mTORC1 activity selectively in resistant lymphoma cells but not in parental cancer cells. Silencing SLC15A3 diminished mTORC1 activity and restored resistant lymphoma sensitivity to 6MP. Strikingly, resistant lymphomas, but not primary tumors, exhibited heightened sensitivity to the clinical mTOR inhibitor, rapamycin, in culture and in vivo. We extended these findings in human lymphoma biopsies, which revealed increased SLC15A3 expression following antimetabolite therapy. Together, our study uncovered a metabolic adaptation that fuels cancer resistance to nucleotide deficiency and positions the mTORC1 inhibitor, rapamycin, as a potential therapeutic strategy for transforming the management of chemotherapy-resistant lymphomas.
科研通智能强力驱动
Strongly Powered by AbleSci AI